Can Patents Be Wiped Out Because Of A Litigator's Misconduct? Regeneron Asks Supreme Court

Regeneron challenges Federal Circuit finding that withholding information in discovery constitutes inequitable conduct; district judge orders firm to pay Merus $10.5m in attorneys' fees and costs.

Macro photo of tooth wheel mechanism with PATENTS concept letters

Regeneron Pharmaceuticals Inc.'s dispute with Merus NV involving a patent on antibody-producing mice has caused an uproar over an appeals court's expansion of inequitable conduct to include behavior by an attorney during litigation.

The inequitable conduct doctrine holds that a patent is unenforceable if the patent applicant is found to have withheld material...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet